Cargando…
Ticagrelor attenuates myocardial ischaemia–reperfusion injury possibly through downregulating galectin‐3 expression in the infarct area of rats
AIMS: The full benefits of myocardial revascularization strategies applied to acute myocardial infarction patients might be reduced by myocardial ischaemia and reperfusion (I/R) injury. It is known that inflammation plays an important role in the pathogenesis of I/R injury and galectin‐3, a known in...
Autores principales: | Liu, Xiaogang, Gu, Ye, Liu, Yufeng, Zhang, Mingjing, Wang, Yuting, Hu, Liqun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980592/ https://www.ncbi.nlm.nih.gov/pubmed/29381821 http://dx.doi.org/10.1111/bcp.13536 |
Ejemplares similares
-
Inhibition of adenosine kinase attenuates myocardial ischaemia/reperfusion injury
por: Wang, Wenjun, et al.
Publicado: (2021) -
Mouse models of myocardial infarction: comparing permanent ligation and ischaemia-reperfusion
por: De Villiers, Carla, et al.
Publicado: (2020) -
Effects of Ticagrelor on Myocardial Infarct Size
por: Hahn, Joo-Yong
Publicado: (2017) -
Pharmacological treatment with galectin-1 protects against renal ischaemia-reperfusion injury
por: Carlos, Carla P., et al.
Publicado: (2018) -
Will Ticagrelor Help Post-Myocardial Infarction ‘Healing’?
por: Park, Kyung Woo
Publicado: (2019)